Civica Rx
Civica Rx provides reliable supplies of quality generic medications. Established by U.S. member hospitals and philanthropic organizations, Civica is the only pharmaceutical company created for the express purpose of preventing and mitigating drug shortages, ensuring the affordable supply of essential medications used in America’s ERs, ICUs and during surgeries. As of October 2025, Civica has provided nearly 250 million units of medications to help treat over 90 million patients.
Civica is making significant progress in bringing its new state-of-the-art Virginia sterile injectable manufacturing facility online. This facility will produce a steady supply of more than three dozen drugs currently in or near shortage status. It will also produce affordable biosimilar insulins, ensuring all Americans have access to lower cost, quality insulins, regardless of their insurance status.
The growing team on site is completing the various qualification and regulatory steps needed to bring each of the facility’s existing filling lines – one for vials, another for pre-filled syringes, and a third for pre-filled pen cartridges – to full operation. Combined, these three production lines will produce more than 200 million units annually, which will tremendously impact the availability and cost of these medicines throughout the country.
Learn more about Civica and join us in doing what is in the best interests of patients.
At Civica, we’re advancing a culture of innovation that is welcoming and inclusive for all, one that runs with solid, “ah-hah” ideas and celebrates exciting milestones and successes. Our purpose and mission are clear, and our values guide our actions. Learn more about what makes us tick.
Our team members make valuable contributions every day on behalf of patients. It is our privilege to invest in the health and well-being of our team members and help them take care of their families through our comprehensive benefits program.
Read what members of our team have to say about joining our company and building our new state-of-the-art manufacturing facility.
Watch how effective partnerships lead to solutions for patients.
